Cheers, chills, and a standing ovation when RASolute 302 showed unprecedented survival on daraxonrasib for patients with progressive pancreatic cancer
Seldom do you sense you’re witnessing a historic moment in cancer care but this feels like ras targeting has arrived
#ASCO26
@TKapetanos I had this condition in my brother (PVT caused by umbilical catheter), he was diagnosed in my med school time, i had very hard time until i understood that he doesn't have cirrhosis
Initiating SGLT2 inhibitors in individuals with diabetes, heart failure, or chronic kidney disease who were taking renin-angiotensin-aldosterone system inhibitors (RAASi) was associated with a lower risk of hyperkalemia. https://t.co/GGJhgUbRlK